Related Experiment Video

Updated: Aug 3, 2026

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
13:42

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Published on: March 8, 2013

Polyclonal antibody effects on the human cardiac 5-HT4(e) receptors depend upon the expression system

Emmanuella Di Scala1, Stéphanie Rose, Olivier Hérault

  • 1UMR CNRS 6542, Physiologie des Cellules Cardiaques et Vasculaires, Faculté des Sciences et Techniques, Université de, Tours, France.

Receptors & Channels
|October 30, 2004
PubMed

Insights

An antibody targeting human heart 5-HT4 receptors showed different effects in Chinese hamster ovary (CHO) and COS-7 cells. This suggests that the expression system can influence 5-HT4 receptor functional behavior.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cell Biology

Background:

  • The 5-HT4 receptor is a G protein-coupled receptor involved in various physiological processes.
  • Understanding receptor behavior in different cellular environments is crucial for drug development.

Purpose of the Study:

  • To investigate the functional effects of an antibody (Anti-G21V) against the human heart 5-HT4 receptor.
  • To compare the receptor's response to the antibody in two different expression systems: Chinese hamster ovary (CHO) and COS-7 cells.

Main Methods:

  • Expression of human heart 5-HT4 receptors in CHO and COS-7 cells.
  • Treatment with the Anti-G21V antibody.
  • Measurement of cyclic adenosine monophosphate (cAMP) levels to assess receptor activity.
  • Analysis of agonist binding affinities (equilibrium constants).

Main Results:

  • The Anti-G21V antibody did not affect basal or 5-HT-stimulated cAMP levels in CHO cells.
  • The antibody exhibited an agonist-like effect on 5-HT4 receptors in COS-7 cells.
  • Differences in equilibrium constants for agonist binding were observed between the two cell types.

Conclusions:

  • The expression system significantly impacts the functional behavior of human heart 5-HT4 receptors.
  • Differences in receptor-ligand interactions, potentially related to equilibrium constants, may explain the varying responses to the Anti-G21V antibody.

More Related Videos

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...